Translational validation of personalized treatment strategy based on genetic characteristics of glioblastoma

PLoS ONE

Volumn 9, Issue 8, 2014, Pages

  Oh, Young Taek ^a,b   Cho, Hee Jin ^a,b   Kim, Jinkuk ^a,c   Lee, Ji Hyun ^d   Rho, Kyoohyoung ^d   Seo, Yun Jee ^a   Choi, Yeon Sook ^a   Jung, Hye Jin ^a   Song, Hyeon Suk ^a   Kong, Doo Sik ^a,b   Seol, Ho Jun ^a,b   Lee, Jung Il ^a,b   Yoon, Yeup ^a,b   Kim, Sunghoon ^d   Nam, Do Hyun ^a,b   Joo, Kyeung Min ^a,b  

^a Samsung Medical Center   (South Korea)

^b Sungkyunkwan University   (South Korea)

^c SAMSUNG Electronics   (South Korea)

^d Seoul National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

BICUCULLINE; CLOMIPRAMINE; GEFITINIB; IRINOTECAN; NICOTINAMIDE ADENINE DINUCLEOTIDE; PACLITAXEL; PRAVASTATIN; TEMOZOLOMIDE; ANTINEOPLASTIC AGENT;

ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL CULTURE; CANCER CLASSIFICATION; CANCER PROGNOSIS; CANCER RESISTANCE; CELL ASSAY; CLONOGENESIS; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENETIC TRAIT; GLIOBLASTOMA; GLIOBLASTOMA CELL LINE; HUMAN; HUMAN CELL; IN VITRO STUDY; MAJOR CLINICAL STUDY; MALE; NEAREST TEMPLATE PREDICTION; NONHUMAN; PERSONALIZED MEDICINE; TREATMENT PLANNING; TUMOR XENOGRAFT; VALIDATION PROCESS; ANIMAL; BRAIN NEOPLASMS; CLUSTER ANALYSIS; DISEASE MODEL; DRUG SCREENING; GENE EXPRESSION PROFILING; GENE REGULATORY NETWORK; GENETICS; GENOMICS; MIDDLE AGED; MOLECULARLY TARGETED THERAPY; MORTALITY; MOUSE; PHARMACOGENETICS; PROGNOSIS; TRANSLATIONAL RESEARCH; TUMOR CELL CULTURE;

ADULT; AGED; ANIMALS; ANTINEOPLASTIC AGENTS; BRAIN NEOPLASMS; CLUSTER ANALYSIS; DISEASE MODELS, ANIMAL; FEMALE; GENE EXPRESSION PROFILING; GENE REGULATORY NETWORKS; GENOMICS; GLIOBLASTOMA; HUMANS; INDIVIDUALIZED MEDICINE; MALE; MICE; MIDDLE AGED; MOLECULAR TARGETED THERAPY; PHARMACOGENETICS; PROGNOSIS; TRANSLATIONAL MEDICAL RESEARCH; TUMOR CELLS, CULTURED; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84928210647     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0103327     Document Type: Article

References (32)

1. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, et al. (2007) The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 114: 97-109.
2. Dolecek TA, Propp JM, Stroup NE, Kruchko C (2012) CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2005-2009. Neuro Oncol 14 Suppl 5: v1-49.
3. Adamson C, Kanu OO, Mehta AI, Di C, Lin N, et al. (2009) Glioblastoma multiforme: a review of where we have been and where we are going. Expert Opin Investig Drugs 18: 1061-1083.
4. Curran WJ Jr, Scott CB, Horton J, Nelson JS, Weinstein AS, et al. (1993) Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials. J Natl Cancer Inst 85: 704-710.
5. Kreth FW, Berlis A, Spiropoulou V, Faist M, Scheremet R, et al. (1998) The role of tumor resection in the treatment of glioblastoma multiforme in adults. Cancer 86: 2117-2123.
6. Scott CB, Scarantino C, Urtasun R, Movsas B, Jones CU, et al. (1998) Validation and predictive power of Radiation Therapy Oncology Group (RTOG) recursive partitioning analysis classes for malignant glioma patients: a report using RTOG 90-06. Int J Radiat Oncol Biol Phys 40: 51-55.
7. Martens T, Laabs Y, Günther HS, Kemming D, Zhu Z, et al. (2008) Inhibition of glioblastoma growth in a highly invasive nude mouse model can be achieved by targeting epidermal growth factor receptor but not vascular endothelial growth factor receptor-2. Clin Cancer Res 14: 5447-5458.
8. Sausville EA, Burger AM (2006) Contributions of human tumor xenografts to anticancer drug development. Cancer Res 66: 3351-3354, discussion 3354.
9. Taillandier L, Antunes L, Angioi-Duprez KS (2003) Models for neurooncological preclinical studies: solid orthotopic and heterotopic grafts of human gliomas into nude mice. J Neurosci Methods 125: 147-157.
10. Verhaak RG, Hoadley KA, Purdom E, Wang V, Qi Y, et al. (2010) Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell 17: 98-110.
11. Lee HS, Bae T, Lee JH, Kim DG, Oh YS, et al. (2012) Rational drug repositioning guided by an integrated pharmacological network of protein, disease and drug. BMC Syst Biol 6: 80.
12. Joo KM, Kim J, Jin J, Kim M, Seol HJ, et al. (2013) Patient-specific orthotopic glioblastoma xenograft models recapitulate the histopathology and biology of human glioblastomas in situ. Cell Rep 3: 260-273.
13. Joo KM, Kim SY, Jin X, Song SY, Kong DS, et al. (2008) Clinical and biological implications of CD133-positive and CD133-negative cells in glioblastomas. Lab Invest 88: 808-815.
14. Ito M, Hiramatsu H, Kobayashi K, Suzue K, Kawahata M, et al. (2002) NOD/SCID/gamma(c)(null) mouse: an excellent recipient mouse model for engraftment of human cells. Blood 100: 3175-3182.
15. Hoshida Y, Toffanin S, Lachenmayer A, Villanueva A, Minguez B, et al. (2010) Molecular classification and novel targets in hepatocellular carcinoma: recent advancements. Semin Liver Dis 30: 35-51.
16. Hoshida Y (2010) Nearest template prediction: a single-sample-based flexible class prediction with confidence assessment. PLoS ONE 5(11): e15543
17. Hegi ME, Diserens AC, Gorlia T, Hamou MF, de Tribolet N, et al. (2005) MGMT gene silencing and benefit from temozolomide in glioblastoma. N Engl J Med 352: 997-1003.
18. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, et al. (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352: 987-996.
19. Charles NA, Holland EC, Gilbertson R, Glass R, Kettenmann H (2011) The brain tumor microenvironment. Glia 59: 1169-1180.
20. Langley RR, Fidler IJ (2011) The seed and soil hypothesis revisited-The role of tumor-stroma interactions in metastasis to different organs. Int J Cancer 128: 2527-2535.
21. Lathia JD, Heddleston JM, Venere M, Rich JN (2011) Deadly teamwork: neural cancer stem cells and the tumor microenvironment. Cell Stem Cell 8: 482-485.
22. DeRose YS, Wang G, Lin YC, Bernard PS, Buys SS, et al. (2011) Tumor grafts derived from women with breast cancer authentically reflect tumor pathology, growth, metastasis and disease outcomes. Nat Med 17: 1514-1520.
23. Fu X, Guadagni F, Hoffman RM (1992) A metastatic nude-mouse model of human pancreatic cancer constructed orthotopically with histologically intact patient specimens. Proc Natl Acad Sci U S A 89: 5645-5649.
24. Giannini C, Sarkaria JN, Saito A, Uhm JH, Galanis E, et al. (2005) Patient tumor EGFR and PDGFRA gene amplifications retained in an invasive intracranial xenograft model of glioblastoma multiforme. Neuro Oncol 7: 164-176.
25. Groves MD, Puduvalli VK, Hess KR, Jaeckle KA, Peterson P, et al. (2002) Phase II trial of temozolomide plus the matrix metalloproteinase inhibitor, marimastat, in recurrent and progressive glioblastoma multiforme. J Clin Oncol 20: 1383-1388.
26. Horten BC, Basler GA, Shapiro WR (1981) Xenograft of human malignant glial tumors into brains of nude mice. A histopatholgical study. J Neuropathol Exp Neurol 40: 493-511.
27. Karam JA, Zhang XY, Tamboli P, Margulis V, Wang H, et al. (2011) Development and characterization of clinically relevant tumor models from patients with renal cell carcinoma. Eur Urol 59: 619-628.
28. Marangoni E, Vincent-Salomon A, Auger N, Degeorges A, Assayag F, et al. (2007) A new model of patient tumor-derived breast cancer xenografts for preclinical assays. Clin Cancer Res 13: 3989-3998.
29. Rubio-Viqueira B, Jimeno A, Cusatis G, Zhang X, Iacobuzio-Donahue C, et al. (2006) An in vivo platform for translational drug development in pancreatic cancer. Clin Cancer Res 12: 4652-4661.
30. Wang J, Miletic H, Sakariassen PO, Huszthy PC, Jacobsen H, et al. (2009) A reproducible brain tumour model established from human glioblastoma biopsies. BMC Cancer 9: 465.
31. Xie Q, Thompson R, Hardy K, DeCamp L, Berghuis B, et al. (2008) A highly invasive human glioblastoma pre-clinical model for testing therapeutics. J Transl Med 6: 77.
32. Zhuo Y, Wu Y, Guo A, Chen S, Su J (2010) Establishment and its biological characteristics of patient-derived lung cancer xenograft models. Zhongguo Fei Ai Za Zhi 13: 568-574.